Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins
This study has been completed.
Study NCT00211029   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received on September 13, 2005.   Last Updated on May 11, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial